ADTX Stock Chart & Stats
$0.43
-$0.03(-13.16%)
At close: 4:00 PM EST
$0.43
-$0.03(-13.16%)
Day’s Range― - ―
52-Week Range<$0.01 - $53,429.11
Previous Close$0.18
Volume28.68M
Average Volume (3M)223.92K
Market Cap
$5.06M
Enterprise Value$3.96M
Total Cash (Recent Filing)$268.85K
Total Debt (Recent Filing)$4.23M
Price to Earnings (P/E)―
Beta1.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1490.72
Shares Outstanding997,976,560
10 Day Avg. Volume193,922
30 Day Avg. Volume223,916
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.20
Price to Sales (P/S)2108.72
P/FCF Ratio>-0.01
Enterprise Value/Market Cap0.78
Enterprise Value/Revenue276.57
Enterprise Value/Gross Profit1.39K
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-22,828,802,400
Revenue Forecast (FY)$1.26M
Aditxt News
ADTX FAQ
What was Aditxt, Inc.’s price range in the past 12 months?
Aditxt, Inc. lowest stock price was <$0.01 and its highest was $53429.11 in the past 12 months.
What is Aditxt, Inc.’s market cap?
Aditxt, Inc.’s market cap is $5.06M.
When is Aditxt, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aditxt, Inc.’s earnings last quarter?
Currently, no data Available
Is Aditxt, Inc. overvalued?
According to Wall Street analysts Aditxt, Inc.’s price is currently Overvalued.
Does Aditxt, Inc. pay dividends?
Aditxt, Inc. does not currently pay dividends.
What is Aditxt, Inc.’s EPS estimate?
Aditxt, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aditxt, Inc. have?
Aditxt, Inc. has 997,976,560 shares outstanding.
What happened to Aditxt, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aditxt, Inc.?
Currently, no hedge funds are holding shares in ADTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aditxt, Inc.
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions. Aditxt also pioneers Apoptotic DNA Immunotherapy, a nucleic acid-based solution that emulates the body's inherent mechanisms for developing self-tolerance to its own tissues. Additionally, Aditxt is actively researching and developing ADi products with diverse therapeutic applications, such as for organ transplant procedures (including skin grafting), various autoimmune conditions, and allergic reactions. The company holds licensing agreements with esteemed institutions like Loma Linda University and Leland Stanford Junior University. Established in 2017, this Richmond, Virginia-headquartered company was initially known as ADiTx Therapeutics, Inc. before rebranding to Aditxt, Inc. in July 2021.
Technical Analysis
Scinai Immunotherapeutics
―
GRI Bio
―
Dermata Therapeutics
―
CERo Therapeutics Holdings
―
CDT Equity
―
Ownership Overview
Options Prices
Currently, No data available
---